4 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
| Phase 2 | 1 | Terminated 1 |
Follow Tinnitus: new trials by email Literature Review of Tinnitus trials Research Report on Tinnitus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Dose Oxytocin Nasal Spray for Treatment of Tinnitus Oxytocin, Placebo nasal spray - Tinnitus | Phase 3 | Terminated | NYU Langone Health | 33 | 2020-01-15 | 2022-10-05 |
| Famvir for Treatment of Hearing in Unilateral Meniere's Disease Famciclovir, Placebo - Meniere's Disease | Phase 3 | Terminated | House Research Institute | 11 | 2011-12-01 | 2021-04-19 |
| Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus Neramexane mesylate - Subjective Tinnitus | Phase 3 | Terminated | Merz Pharmaceuticals GmbH | 821 | 2009-01-01 | 2012-11-28 |
| Gabapentin for the Treatment of Tinnitus Gabapentin (Neurontin) - Tinnitus | Phase 2 / Phase 3 | Terminated | Washington University School of Medicine | 160 | 2004-04-01 | 2012-03-02 |
Hearing Loss (1) · Meniere Disease (1) · Vertigo (1)
Ear Diseases (4) · Hearing Disorders (4) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Otorhinolaryngologic Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Sensation Disorders (4) · Signs and Symptoms (4) · Endolymphatic Hydrops (1) · Labyrinth Diseases (1) · Vestibular Diseases (1)
Famciclovir (1) · Gabapentin (1) · Oxytocin (1)
House Research Institute (1) · Merz Pharmaceuticals GmbH (1) · NYU Langone Health (1) · Washington University School of Medicine (1)
United States (2) · Austria (1) · Belgium (1) · Brazil (1) · Czechia (1) · France (1) · Germany (1) · Mexico (1) · Netherlands (1) · Poland (1) · Portugal (1) · South Africa (1) · Spain (1) · United Kingdom (1)
Jay F Piccirillo, MD (1) · Jennifer Derebery, MD (1) · Lawrence Newman, MD (1)
2008 (1), R01DC006253 (1)